Reagent Portfolio Expansion

About CellaVision

CellaVision is a global leader in digital hematology microscopy, founded in 1994 with a mission to automate and standardize manual blood cell analysis. The company has achieved a dominant position with over 8,000 units installed in more than 40 countries, driven by its integrated platform of instruments, reagents, and AI-enhanced software. Its strategy focuses on continuous innovation to expand its solution ecosystem, deepen laboratory workflow integration, and leverage artificial intelligence to solidify its standard-of-care status in clinical laboratories worldwide.

Therapeutic Areas